Rating:
Buy CXM
77.27 %
Cardium Therapeutics Inc. (CXM) rated Buy with price target $5 by Lazard Capital
Lazard Capital rated Buy Cardium Therapeutics Inc. (AMEX: CXM) on 05/02/2008, when the stock price was $2.20.
Since then, Cardium Therapeutics Inc. has lost 77.27% as of 03/19/2010's recent price of $0.50. If you would have followed this Lazard Capital's recommendation on CXM, you would have lost 77.27% of your investment.